logo
Cardiac Event Monitor Market Set to Reach USD 7.39 Bn by 2032 with 5.9% CAGR

Cardiac Event Monitor Market Set to Reach USD 7.39 Bn by 2032 with 5.9% CAGR

Globe and Mail7 hours ago

The market trend for the cardiac event monitor market is driven by several factors, including the increasing prevalence of cardiovascular diseases, the growing geriatric population, and the rising adoption of remote monitoring technologies. Additionally, the development of advanced and user-friendly cardiac event monitors, coupled with the increasing demand for home-based healthcare solutions, is expected to further fuel market growth during the forecast period.
Cardiac Event Monitor Market Insights
The Cardiac Event Monitor market is witnessing robust business growth driven by rising cardiovascular disease prevalence and digital health integration. Advanced monitoring solutions are reshaping industry size and fueling market analysis for stakeholders seeking deeper market insights. This outlook aligns with the market forecast through 2032 and reflects evolving market dynamics.
The Global Cardiac Event Monitor market size is estimated to be valued at USD 4.95 Bn in 2025 and is expected to reach USD 7.39 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. This market report highlights the expansion of external and implantable monitoring devices, underpinned by rising arrhythmia detection demand. Recent market research indicates that 2024 shipments surpassed 1.3 million units globally, underpinning revenue growth across North America and Europe. The Cardiac Event Monitor market report offers detailed market segments, market drivers, and market restraints for strategic planning.
https://www.coherentmarketinsights.com/insight/request-sample/7905
Market Key Takeaways
Regions:
• North America: Strong reimbursement frameworks driving early adoption of advanced monitors.
• Latin America: Growing investments in telehealth infrastructure boosting device penetration.
• Europe: Government initiatives for cardiac care expansion fueling demand.
• Asia Pacific: Rapid urbanization and rising healthcare expenditure accelerating uptake.
• Middle East: Infrastructure upgrades in GCC countries supporting remote monitoring.
• Africa: Pilot programs and NGO funding enhancing diagnostic access.
Segments:
• Device Type – External Loop Recorders, Implantable Loop Recorders (e.g., long-term arrhythmia use cases).
• End User – Hospitals & Clinics, Ambulatory Care Centers (use case: continuous outpatient monitoring).
• Application – Arrhythmia Detection, Syncope Management (example: post-stroke cardiac surveillance).
Growth Factors
• Cardiovascular Disease Surge: In 2024, global arrhythmia diagnoses rose by 7.2%, driving market growth.
• Telehealth Reimbursement Expansion: U.S. reimbursement policies now cover up to 85% of remote monitoring costs, up from 60% in 2023.
• Aging Population: By 2025, adults over 65 will constitute 18% of Europe's population, boosting market opportunities for long-term monitoring.
• Technological Innovation: Integration of AI-driven analytics enhanced diagnostic accuracy by 15% in pilot trials during early 2024.
• Market drivers include rising patient self-care and regulatory support, offsetting market restraints like high device costs.
Book the Latest Edition of this Market Study Get Up to 25 % Discount: https://www.coherentmarketinsights.com/insight/buy-now/7905
Market Trends
• Telemonitoring Platforms: Adoption of cloud-based cardiac event platforms grew 22% in 2024, reshaping Cardiac Event Monitor market trends.
• Wearable Integration: Hybrid monitors pairing wearable patches with smartphone apps increased user compliance by 12% year-on-year.
• AI-Enabled Analytics: In 2025, AI algorithms reduced false-positive alerts by 25% in clinical deployments.
• Miniaturization: Implantable monitors shrank by 30% in size between 2023 and 2025, expanding pediatric applications.
• Subscription Models: Recurring-revenue models contributed 18% of total market revenue in 2024, illustrating evolving market scope.
Actionable Insights
• Production Capacity: Global manufacturing capacity reached 1.6 million units in 2024, up 9% from 2023.
• Pricing Trends: Average selling price per device declined by 3% in 2024, enhancing affordability.
• Exports & Imports: Exports expanded by 11% in 2024, led by Europe; imports rose 7% in Asia Pacific, signaling market opportunities.
• Use Cases: Remote patient management deployments increased 14% in 2025, with hospitals accounting for 60% of demand.
• Micro-Indicators: Drill-down data show outpatient clinics growing device orders by 8% per quarter in 2024.
• Nano-Indicators: Country-level permit approvals jumped by 20% in emerging markets, reflecting favorable market dynamics.
Key Players
• Medtronic
• Boston Scientific Corporation
• Abbott
• GE Healthcare
• Philips Healthcare
• Biotronik
• Hill-Rom Holdings (Baxter)
• iRhythm Technologies
• Preventice Solutions
• Medicomp
• ACS Diagnostics
• Spacelabs Healthcare
• Nihon Kohden Corporation
Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/7905
Competitive Strategies:
• Medtronic expanded its Asia Pacific distribution network in 2024, boosting Cardiac Event Monitor market share by 4.5%.
• Boston Scientific implemented value-based pricing in Europe, leading to a 10% uplift in Cardiac Event Monitor market revenue during H1 2025.
• Philips Healthcare's strategic partnership with remote care platforms reduced device latency by 20%, enhancing customer retention and differentiating its offerings.
Frequently Asked Questions
1. Who are the dominant players in the Cardiac Event Monitor market?
Major market players include Medtronic, Boston Scientific, Abbott, GE Healthcare and Philips Healthcare, collectively driving product innovation and global reach.
2. What will be the size of the Cardiac Event Monitor market in the coming years?
The market is projected to grow from USD 4.95 Bn in 2025 to USD 7.39 Bn by 2032, at a CAGR of 5.9%, according to the latest market forecast.
3. Which end-user industry has the largest growth opportunity?
Hospitals and ambulatory care centers represent the largest growth opportunity, driven by continuous outpatient monitoring and integrated telehealth services.
4. How will market development trends evolve over the next five years?
Key trends include AI-driven analytics, wearable integration, subscription models, and miniaturization, all reshaping market dynamics and creating new business growth avenues.
5. What is the nature of the competitive landscape and challenges in the Cardiac Event Monitor market?
The landscape is consolidated among a few large companies focusing on innovation. Challenges include high device costs, reimbursement variability and stringent regulatory approvals.
6. What go-to-market strategies are commonly adopted in the Cardiac Event Monitor market?
Strategies encompass regional partnerships, value-based pricing, digital platform integration, and direct-to-consumer telemonitoring services to enhance market penetration and customer engagement.
About Coherent Market Insights
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

‘Wrong side of history': B.C.'s decision not to cover terminally ill girl's treatment met with sharp criticism
‘Wrong side of history': B.C.'s decision not to cover terminally ill girl's treatment met with sharp criticism

CTV News

timean hour ago

  • CTV News

‘Wrong side of history': B.C.'s decision not to cover terminally ill girl's treatment met with sharp criticism

In a social media post an emotional mother is reacting to the news B.C. will not continue funding an expensive drug treatment for her nine-year-old daughter's rare disease. Charleigh Pollock suffers from Batten disease, a rare and fatal neurodegenerative disorder. Her mom, Jori Fales, choked back tears while providing an update on her daughter's final treatment. 'Our family is heartbroken,' said Fales. 'We are processing this news and at this time there just not much else I can say.' Racked with grief, Fales addresses her daughter directly. 'I'm just really sorry Charleigh and we love you so much,' she said. The emotional cascade came Wednesday, after a message from B.C.'s Health Minister Josie Osborne on saying the province will no longer cover a drug called Brinearu. 'There is no evidence to support changing the discontinuation criteria or to support the ministry continuing to provide coverage … given the advanced stage of Charleigh's condition,' said Osborne. But Charleigh's mother says the treatments for a disease that will eventually kill her daughter are still working. 'I want the facts to be straight here,' Fales said. 'My daughter is not in advanced decline and she has been stable for years on this medication. So, that comment made my blood boil yesterday.' After several extensions from the province, Thursday was the nine-year-old's final infusion treatment with the costly drug. 'I took a picture this morning for her last infusion, and she has a huge smile on her face,' said Fales. 'Everyone's heart is breaking in the hospital, and this is just a really sad day for everyone.' Lori Brown, president of Batten Disease Support & Research Association Canada, says Charleigh is the only child that she is aware of to have been taken off of the drug by anyone other than their medical team or parents. 'B.C. is on the wrong side of history if they stick with this decision,' said Brown, adding that the province's decision has sent shockwaves through the small yet global Batten Disease community. 'They're rattled, they hear that one child is being taken off and they say, 'OK, what about my child?' What lies ahead for Charleigh is unknown, but her mother says she expects to have to make some heartbreaking decisions and face a devastating reality. 'Charleigh turns 10 in two weeks and I know in my soul we will not see her 11th birthday, and I am angry about that,' said Fales.

Edmontonians top blood donors, new centre aims to further improve numbers
Edmontonians top blood donors, new centre aims to further improve numbers

CTV News

timean hour ago

  • CTV News

Edmontonians top blood donors, new centre aims to further improve numbers

Donors give blood at the grand opening of the new Canadian Blood Services' Edmonton collection centre on June 19, 2025. (Galen McDougall/CTV News Edmonton) Edmonton is vying to be the top contender in Canada in blood donations and officials say a new centre could help. Canadian Blood Services (CBS) held a grand opening for its new centre on 106 Street and 42 Avenue on Thursday. Dr. Graham Sher, CBS CEO, said the new centre is one of Canada's largest and offers an improved experience for staff and donors, which is critical in keeping repeat donors. 'Donors tell us consistently that one of the most important things they want in order to keep coming back is time and convenience,' he said, adding the new centre is more spacious, efficient and easier to park at. There are 42 collection centres across Canada, but not all do what the Edmonton centre does in collecting plasma and platelets as well. Plasma, the liquid part of blood, is in particularly high demand, Sher said. 'Because from plasma, we can make many, many important drugs – life-saving drugs,' he said. 'And the demand for these plasma-derived drugs is growing enormously.' Jacob Guziak Jacob Guziak (right) and his mother Andrea Fernandez attend the grand opening of the new Canadian Blood Services' Edmonton collection centre on June 19, 2025. (Galen McDougall/CTV News Edmonton) Jacob Guziak was born with an immune disorder known as bubble-boy disorder. He has relied on monthly treatments with plasma products since he was a baby. 'Donors are very important, because they are the ones giving us these antibodies that Jacob cannot create yet,' said his mother Andrea Fernandez. 'In reality, every donor is giving us another birthday, another smile, another day.' Sher said it can take thousands of plasma donors to make the treatment Guziak needs each month. He hopes the improved experience at the Edmonton centre will help the city continue to be a top collector. 'We would love Edmonton to keep performing the way it is, and if it became the top performer in the country, that would be amazing,' he added. The new centre opened for donations in late April. You can check your eligibility to donate blood or book an appointment on the CBS website.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store